Search research articles
Contact Us
Filters
Showing results (401-410 of 945) with videos related to
Page
of 95
Sort By:
Diagnostic Microbiology and Infectious Disease
|
October 1, 1994
Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group
R N Jones, H S Sader, M E Erwin
Diagnostic Microbiology and Infectious Disease
|
January 1, 1989
Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaxime
P C Fuchs, R N Jones, A L Barry
The Journal of Antimicrobial Chemotherapy
|
January 1, 1986
In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors
A L Barry, R N Jones, R R Packer
Diagnostic Microbiology and Infectious Disease
|
December 1, 1995
Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agents
M G Cormican, S A Marshall, R N Jones
Journal of Clinical Microbiology
|
August 1, 1996
Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen
M G Cormican, S A Marshall, R N Jones
Diagnostic Microbiology and Infectious Disease
|
May 1, 1985
BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents
R N Jones, A L Barry, R R Packer
Diagnostic Microbiology and Infectious Disease
|
January 5, 2002
Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA)
M A Pfaller, R N Jones, D J Biedenbach, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
November 20, 2001
Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil
H S Sader, A C Gales, R N Jones
Diagnostic Microbiology and Infectious Disease
|
June 19, 2003
Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae
T R Anderegg, D J Biedenbach, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1987
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria
P C Fuchs, R N Jones, A L Barry
Page
of 95
Search research articles
Search
Showing results (401-410 of 945) with videos related to
Sort By:
Page
of 95
Diagnostic Microbiology and Infectious Disease
|
October 1, 1994
Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group
R N Jones, H S Sader, M E Erwin
Diagnostic Microbiology and Infectious Disease
|
January 1, 1989
Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaxime
P C Fuchs, R N Jones, A L Barry
The Journal of Antimicrobial Chemotherapy
|
January 1, 1986
In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors
A L Barry, R N Jones, R R Packer
Diagnostic Microbiology and Infectious Disease
|
December 1, 1995
Preliminary interpretive criteria for disk diffusion susceptibility testing of SCH 27899, a compound in the everninomicin class of antimicrobial agents
M G Cormican, S A Marshall, R N Jones
Journal of Clinical Microbiology
|
August 1, 1996
Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen
M G Cormican, S A Marshall, R N Jones
Diagnostic Microbiology and Infectious Disease
|
May 1, 1985
BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents
R N Jones, A L Barry, R R Packer
Diagnostic Microbiology and Infectious Disease
|
January 5, 2002
Antimicrobial resistance trends in medical centers using carbapenems: report of 1999 and 2000 results from the MYSTIC program (USA)
M A Pfaller, R N Jones, D J Biedenbach, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
November 20, 2001
Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil
H S Sader, A C Gales, R N Jones
Diagnostic Microbiology and Infectious Disease
|
June 19, 2003
Re-evaluation of quality control guidelines for gatifloxacin and garenoxacin (BMS284756) when susceptibility testing Haemophilus influenzae and Streptococcus pneumoniae
T R Anderegg, D J Biedenbach, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease
|
September 1, 1987
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria
P C Fuchs, R N Jones, A L Barry
Page
of 95